BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 29046370)

  • 1. Excessive glucocorticoid-induced muscle MuRF1 overexpression is independent of Akt/FoXO1 pathway.
    Wang XJ; Xiao JJ; Liu L; Jiao HC; Lin H
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29046370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycine Regulates Protein Turnover by Activating Protein Kinase B/Mammalian Target of Rapamycin and by Inhibiting MuRF1 and Atrogin-1 Gene Expression in C2C12 Myoblasts.
    Sun K; Wu Z; Ji Y; Wu G
    J Nutr; 2016 Dec; 146(12):2461-2467. PubMed ID: 27798331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imoxin prevents dexamethasone-induced promotion of muscle-specific E3 ubiquitin ligases and stimulates anabolic signaling in C2C12 myotubes.
    Eo H; Reed CH; Valentine RJ
    Biomed Pharmacother; 2020 Aug; 128():110238. PubMed ID: 32450522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitin E3 ligase Atrogin-1 protein is regulated via the rapamycin-sensitive mTOR-S6K1 signaling pathway in C2C12 muscle cells.
    Nishimura Y; Chunthorng-Orn J; Lord S; Musa I; Dawson P; Holm L; Lai YC
    Am J Physiol Cell Physiol; 2022 Jul; 323(1):C215-C225. PubMed ID: 35704697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
    Castillero E; Alamdari N; Lecker SH; Hasselgren PO
    Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids.
    Baehr LM; Furlow JD; Bodine SC
    J Physiol; 2011 Oct; 589(Pt 19):4759-76. PubMed ID: 21807613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoids Enhance Muscle Proteolysis through a Myostatin-Dependent Pathway at the Early Stage.
    Wang R; Jiao H; Zhao J; Wang X; Lin H
    PLoS One; 2016; 11(5):e0156225. PubMed ID: 27227776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-Hydroxy-β-methylbutyrate facilitates PI3K/Akt-dependent mammalian target of rapamycin and FoxO1/3a phosphorylations and alleviates tumor necrosis factor α/interferon γ-induced MuRF-1 expression in C2C12 cells.
    Kimura K; Cheng XW; Inoue A; Hu L; Koike T; Kuzuya M
    Nutr Res; 2014 Apr; 34(4):368-74. PubMed ID: 24774073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy.
    Léger B; Cartoni R; Praz M; Lamon S; Dériaz O; Crettenand A; Gobelet C; Rohmer P; Konzelmann M; Luthi F; Russell AP
    J Physiol; 2006 Nov; 576(Pt 3):923-33. PubMed ID: 16916907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.
    Sacheck JM; Ohtsuka A; McLary SC; Goldberg AL
    Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E591-601. PubMed ID: 15100091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMP-activated protein kinase enhances the expression of muscle-specific ubiquitin ligases despite its activation of IGF-1/Akt signaling in C2C12 myotubes.
    Tong JF; Yan X; Zhu MJ; Du M
    J Cell Biochem; 2009 Oct; 108(2):458-68. PubMed ID: 19639604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron-induced skeletal muscle atrophy involves an Akt-forkhead box O3-E3 ubiquitin ligase-dependent pathway.
    Ikeda Y; Imao M; Satoh A; Watanabe H; Hamano H; Horinouchi Y; Izawa-Ishizawa Y; Kihira Y; Miyamoto L; Ishizawa K; Tsuchiya K; Tamaki T
    J Trace Elem Med Biol; 2016 May; 35():66-76. PubMed ID: 27049128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sepsis increases the expression and activity of the transcription factor Forkhead Box O 1 (FOXO1) in skeletal muscle by a glucocorticoid-dependent mechanism.
    Smith IJ; Alamdari N; O'Neal P; Gonnella P; Aversa Z; Hasselgren PO
    Int J Biochem Cell Biol; 2010 May; 42(5):701-11. PubMed ID: 20079455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486.
    Xu J; Li R; Workeneh B; Dong Y; Wang X; Hu Z
    Kidney Int; 2012 Aug; 82(4):401-11. PubMed ID: 22475820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.
    Stitt TN; Drujan D; Clarke BA; Panaro F; Timofeyva Y; Kline WO; Gonzalez M; Yancopoulos GD; Glass DJ
    Mol Cell; 2004 May; 14(3):395-403. PubMed ID: 15125842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the FoxO1/MuRF1/Atrogin-1 Signaling Pathway in the Oxidative Stress-Induced Atrophy of Cultured Chronic Obstructive Pulmonary Disease Myotubes.
    Pomiès P; Blaquière M; Maury J; Mercier J; Gouzi F; Hayot M
    PLoS One; 2016; 11(8):e0160092. PubMed ID: 27526027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of inducible nitric oxide synthase attenuates immobilization-induced skeletal muscle atrophy in mice.
    Bae SK; Cha HN; Ju TJ; Kim YW; Kim HS; Kim YD; Dan JM; Kim JY; Kim SD; Park SY
    J Appl Physiol (1985); 2012 Jul; 113(1):114-23. PubMed ID: 22518831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy.
    Verhees KJ; Schols AM; Kelders MC; Op den Kamp CM; van der Velden JL; Langen RC
    Am J Physiol Cell Physiol; 2011 Nov; 301(5):C995-C1007. PubMed ID: 21832246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms involved in 3',5'-cyclic adenosine monophosphate-mediated inhibition of the ubiquitin-proteasome system in skeletal muscle.
    Gonçalves DA; Lira EC; Baviera AM; Cao P; Zanon NM; Arany Z; Bedard N; Tanksale P; Wing SS; Lecker SH; Kettelhut IC; Navegantes LC
    Endocrinology; 2009 Dec; 150(12):5395-404. PubMed ID: 19837877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of short-term cold exposure on skeletal muscle protein breakdown in rats.
    Manfredi LH; Zanon NM; Garófalo MA; Navegantes LC; Kettelhut IC
    J Appl Physiol (1985); 2013 Nov; 115(10):1496-505. PubMed ID: 23908317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.